AI assistant
Sending…
SYNLOGIC, INC. — Director's Dealing 2019
Sep 18, 2019
35028_dirs_2019-09-18_ee49d4a9-0c0d-4f8f-a1c9-6c45eb4a72be.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SYNLOGIC, INC. (SYBX)
CIK: 0001527599
Period of Report: 2019-09-16
Reporting Person: Riese Richard J. (Chief Medical Officer)
More from SYNLOGIC, INC.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Jan 29
Major Shareholding Notification
2026
Jan 23
Regulatory Filings
2026
Jan 20
Regulatory Filings
2025
Dec 16
Regulatory Filings
2025
Nov 26
Interim / Quarterly Report
2025
Nov 13
Major Shareholding Notification
2025
Nov 13
Annual Report
2025
Nov 12
Proxy Solicitation & Information Statement
2025
Nov 12